- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05771766
Postural Drainage With and Without Aerobic Training on Chronic Suppurative Lung Disease
July 31, 2023 updated by: Riphah International University
Effects of Postural Drainage With and Without Aerobic Training on Respiratory Rate, Oxygen Saturation and Endurance in Chronic Suppurative Lung Disease
This will be a randomized controlled trial Patients will be divided into two groups randomly.
Both groups will receive postural drainage as baseline treatment thrice a week for two weeks.
The intervention group will undergo additional Aerobic Training thrice a week for two weeks as well along with postural drainage.
Aerobic training will include a 5-step stair-climbing and a 10-step walk during each session.
Data will be collected before and at the end of two weeks.
Respiratory Rate, Pulse Oximeter, 10-meter Endurance walk test, and Pediatric Cough Questionnaire will be used to collect data pre and post-treatment.
Data will be analyzed by use of SPSS Version 2010.
Data will be presented in the form of mean and standard deviation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Chronic suppurative lung disease (csld) is a clinical syndrome in children with respiratory symptoms and signs.
Children who have bronchiectasis symptoms but non-diagnostic scans are described as having chronic suppurative lung disease (csld).
Postural drainage improves secretion clearance techniques, it is equally as effective as other airway clearance techniques.
This study will focus on the implementation of postural drainage and aerobic training in this disease to find their effect on respiratory rate, oxygen saturation, and endurance.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan, 5400
- Gulab Devi teaching hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 13 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age of 5-13 years
- Medically stable,
- Patients must have 2 episodes of productive cough, each episode lasting for 4 weeks per year.
Exclusion Criteria:
- Non-Chronic Suppurative Lung Disease related chronic disease
- Chronic Suppurative Lung Disease-related conditions posing an increased risk to the patient when exercising.
children with any MSK-disorder or gait abnormalities
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Postural Drainage with Aerobic Training
The intervention group will undergo Postural Drainage and additional Aerobic Training thrice a week for two weeks as well along with postural drainage.
Aerobic training will include a 5-step stair-climbing and 10-step walk during each session.
|
This will be a randomized controlled trial Patients will be divided into two groups randomly.
Both groups will receive postural drainage as baseline treatment thrice a week for two weeks.
The intervention group will undergo additional Aerobic Training thrice a week for two weeks as well along with postural drainage.
Aerobic training will include 5-step stair-climbing and 10 step walk during each session.
|
|
Active Comparator: Postural Drainage
the group will receive postural drainage as baseline treatment thrice a week for two weeks.
|
Postural Drainage
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Respiratory Rate
Time Frame: 2 weeks
|
The respiratory rate is the rate at which breathing occurs; it is set and controlled by the respiratory center of the brain.
|
2 weeks
|
|
Oxygen Saturation
Time Frame: 2 Weeks
|
Oxygen saturation is the fraction of oxygen-saturated hemoglobin relative to total hemoglobin in the blood.
|
2 Weeks
|
|
10 Meter Walk Test
Time Frame: 2 Weeks
|
The individual is instructed to walk a set distance (6 meters, 10 meters, etc).
Time is measured while the individual walks the set distance (often the individual is given space to accelerate to his/her preferred walking speed
|
2 Weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
5-item Pediatric Cough Questionnair
Time Frame: 2 Weeks
|
Used to measure frequency of child's cough with aa 6-point Likert-scale.
Questionnair have 5 Questions to be answered by parent.
|
2 Weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Arnab Altaf, Mphill, Riphah International University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 15, 2022
Primary Completion (Actual)
October 5, 2022
Study Completion (Actual)
December 5, 2022
Study Registration Dates
First Submitted
January 4, 2023
First Submitted That Met QC Criteria
March 15, 2023
First Posted (Actual)
March 16, 2023
Study Record Updates
Last Update Posted (Actual)
August 1, 2023
Last Update Submitted That Met QC Criteria
July 31, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC/RCR& AHS/22/0737
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Disease Chronic
-
Sygehus LillebaeltDanmarks Lungeforening; Chiesi Foundation; Overlæge Jørgen Werner Schous og hustru...Active, not recruitingChronic Obstructive Pulmonary DiseaseDenmark
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
Breathe Technologies, Inc.CompletedPulmonary Disease, Chronic Obstructive | Chronic Obstructive Lung Disease | Chronic Obstructive Airway Disease | Airflow Obstruction, ChronicUnited States
-
Aveiro UniversityPrograma Operacional Inclusão Social e Emprego (POISE); Programa Operacional... and other collaboratorsCompletedLung Diseases | Chronic Obstructive Pulmonary Disease | Pulmonary Disease | Interstitial Lung Disease | Chronic Respiratory DiseasePortugal
-
Centre Hospitalier Intercommunal CreteilInstitut National de la Santé Et de la Recherche Médicale, France; Henri Mondor...RecruitingChronic Obstructive Pulmonary Disease | Chronic Obstructive Lung DiseaseFrance
-
Assistance Publique - Hôpitaux de ParisCompletedChronic Obstructive Lung Disease (COLD)France
-
Breathe Technologies, Inc.CompletedPulmonary Disease, Chronic Obstructive | Chronic Obstructive Lung Disease | Chronic Obstructive Airway Disease | Airflow Obstruction, ChronicUnited States
-
Laval UniversityInstitut universitaire de cardiologie et de pneumologie de Québec, University... and other collaboratorsRecruitingInterstitial Lung Disease | COPD Chronic Obstructive Pulmonary DiseaseCanada, France
-
Sissel Kronborg-WhiteNot yet recruitingChronic Obstructive Pulmonary Disease | Interstitial Lung Disease
-
Beni-Suef UniversityCompleted
Clinical Trials on Postural Drainge and aerobic training
-
University Hospital, RouenNot yet recruitingMen Who Have Undergone ProstatectomyFrance
-
University of Alabama at BirminghamCompletedCystic FibrosisUnited States
-
Rosimeire Simprini PadulaCompletedOccupational Exposure
-
Hadassah Medical OrganizationCompletedThe Influence of Different Training Regimens on Electrical Stability Following Myocardial InfarctionIschemic Heart Disease | Congestive Heart FailureIsrael
-
General Hospital Murska SobotaUniversity of Primorska; University of LjubljanaUnknownCoronary Artery Disease | Heart Failure With Reduced Ejection FractionSlovenia
-
National Yang Ming UniversityNot yet recruiting
-
University of Texas Southwestern Medical CenterRecruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Duke UniversityCompleted
-
University of BarcelonaCompleted